11.24

1.44% 0.1481

Perrigo Company Plc (PRGO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$11.09

Offen:

$11.19

24-Stunden-Volumen:

2.18M

Relative Volume:

0.67

Marktkapitalisierung:

$1.56B

Einnahmen:

$4.18B

Nettoeinkommen (Verlust:

$-1.79B

KGV:

-0.8576

EPS:

-13.1048

Netto-Cashflow:

$107.70M

1W Leistung:

+8.28%

1M Leistung:

+3.88%

6M Leistung:

-22.89%

1J Leistung:

-57.93%

1-Tages-Spanne:

$11.19

$11.59

1-Wochen-Bereich:

$10.21

$11.59

52-Wochen-Spanne:

$9.225

$28.43

Perrigo Company Plc Stock (PRGO) Company Profile

Firmenname

Perrigo Company Plc

Sektor

Healthcare (1100)

Branche

Drug Manufacturers - Specialty & Generic (86)

Telefon

269-673-8451

Adresse

THE SHARP BUILDING, DUBLIN 2

Mitarbeiter

8,100

Twitter

@perrigocompany

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

PRGO's Discussions on Twitter

Compare PRGO vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PRGO Perrigo Company Plc	11.24	1.53B	4.18B	-1.79B	107.70M	-13.10
TAK Takeda Pharmaceutical Co Adr	16.98	53.37B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.845	42.80B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.60	41.09B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.03	31.62B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	558.72	23.23B	3.17B	1.29B	1.01B	27.09

Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-06	Herabstufung	JP Morgan	Overweight → Neutral
2025-01-14	Herabstufung	Argus	Buy → Hold
2025-01-06	Herabstufung	Piper Sandler	Overweight → Neutral
2024-09-24	Fortgesetzt	Jefferies	Hold
2023-11-17	Eingeleitet	Piper Sandler	Overweight
2023-03-07	Eingeleitet	Canaccord Genuity	Buy
2022-09-14	Hochstufung	Argus	Hold → Buy
2022-09-06	Hochstufung	Wells Fargo	Equal Weight → Overweight
2021-10-14	Hochstufung	Raymond James	Mkt Perform → Outperform
2021-09-30	Hochstufung	Jefferies	Hold → Buy
2021-04-07	Fortgesetzt	RBC Capital Mkts	Sector Perform
2021-01-06	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2020-04-17	Herabstufung	Argus	Buy → Hold
2020-03-24	Hochstufung	JP Morgan	Neutral → Overweight
2020-03-20	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2020-03-18	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2019-10-11	Hochstufung	Argus	Hold → Buy
2019-03-20	Eingeleitet	SunTrust	Hold
2018-11-13	Herabstufung	Berenberg	Buy → Hold
2018-08-10	Bestätigt	Stifel	Hold
2018-07-30	Herabstufung	Argus	Buy → Hold
2018-07-12	Herabstufung	Goldman	Neutral → Sell
2018-01-03	Eingeleitet	Leerink Partners	Mkt Perform
2017-12-08	Hochstufung	Argus	Hold → Buy
2017-11-10	Hochstufung	RBC Capital Mkts	Underperform → Sector Perform
2017-10-05	Bestätigt	UBS	Buy
2017-09-07	Eingeleitet	Oppenheimer	Outperform
2017-08-11	Hochstufung	Goldman	Sell → Neutral
2017-08-11	Bestätigt	RBC Capital Mkts	Underperform
2017-06-16	Eingeleitet	Cantor Fitzgerald	Overweight
2017-06-05	Herabstufung	RBC Capital Mkts	Sector Perform → Underperform
2017-03-03	Bestätigt	B. Riley & Co.	Neutral

Alle ansehen

Perrigo Company Plc Aktie (PRGO) Neueste Nachrichten

03:23 AM

Enterprise value to revenue forward of Perrigo Company plc – NYSE:PRGO - TradingView

03:23 AM

Jul 06, 2026

Perrigo Company plc Files Form 8-K for NYSE-Listed Ordinary Shares and Senior Notes – Corporate Details and Security Listings – Minichart - Minichart

Jul 06, 2026

Perrigo (PRGO) details interim CEO Albert Manzone’s 2026 pay package - Stock Titan

Jul 06, 2026

Perrigo (PRGO) reinstates executive severance policy tied to CEO transition - Stock Titan

Jul 06, 2026

Jul 05, 2026

Jefferies lowers Perrigo stock price target to $14 on weak quarter - Investing.com

Jul 05, 2026

Jul 04, 2026

PRGOPerrigo Company plc Options - Finviz

Jul 04, 2026

The Store Brand Ibuprofen Tablets from PerrigoB2B pain reliever powering US pharmacy shelves - AD HOC NEWS

Jul 04, 2026

Jul 03, 2026